ImmunityBio, Inc.

Healthcare · Biotechnology · United States

Last price 8.27 USD (Oct 30, 2026, 12:41 PM EDT) · Market cap 8.76B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient’s immune system and deliver durable protection against cancer and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion proteins, DNA and vaccine vectors, and cell therapies. The company’s platform has generated first-in-human therapeutic agents that are planned to be studied in clinical trials in liquid and so...